Genexine, Inc. is a publicly traded, clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation . Its primary technology platforms are Therapeutic DNA vaccine and hyFc® long-acting technology and bioPROTAC. The company has multiple products in clinical development including several undergoing Phase 3 registrational trials.
The company's proprietary pipeline includes GX-188E (tirvalimogene teraplasmid) for head and neck cancer and cervical cancer, GX-I7 (efineptakin alfa) for multiple solid cancers and ARS, GX-H9 (eftansomatropin alfa) for Pediatric Growth Hormone Deficiency and GX-E4 for CKD-induced anemia, among others.
in 2024, Genexine has completed a merger with 'EPD biotherapeutics' and acquired future focusing new modality 'bioPROTAC' platform technology which now in pre-clinical development focusing on oncology.
The company has established multiple partnerships with global companies in order to expedite product development and commercialization and create significant value.
Genexine is listed on the Korean exchange (KOSDAQ: 095700) and is headquartered in Seoul, Korea. Genexine is committed to the well-being and care of patients worldwide.
For more information about Genexine, please visit at www.genexine.com.
Company Details
- Employees
- 48
- Founded
- -
- Address
- 172, Magokjungang-Ro, Bio Innovation Park,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.genexine.com
- Keywords
- TPD, PROTAC, bioPROTAC, biobetter, immuno-oncology, first-in-class, oncology, growth hormone, anemia, long acting drugs, cancer vaccine, GLP-1, protein degrader, interleukin-7, atopic dermatitis, nanobody.
- HQ
- Gangseo-gu, Seoul-si
Genexine, Inc. Questions
Genexine, Inc.'s website is http://www.genexine.com
Genexine, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/genexine
Genexine, Inc. has
48 employees.
View email and phone details for 48
employees at Genexine, Inc..
Genexine, Inc.'s industry is
Biotechnology Research
Genexine, Inc.'s top competitors are
Sk Biopharmaceuticals,
Aprogen,
Epd Biotherapeutics Inc.,
Sk Bioscience,
Lotte Biologics,
Tj Biopharma,
Jw Pharmaceutical Corporation,
Kgbio,
Neoimmunetech,
Handok.
Genexine, Inc.'s categories are Biotechnology Research
Genexine, Inc.'s founding year is 1999
